$6.16 -0.02 (-0.37%)
11/23/2009 4:00 PM

Allos Therapeutics, Inc. (ALTH)

CAPS Rating: 5 out of 5

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Featured Broker Partners